1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Gene–environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          We previously reported a relationship between air pollutants and increased risk of pediatric-onset multiple sclerosis (POMS). Ozone is an air pollutant that may play a role in multiple sclerosis (MS) pathoetiology. CD86 is the only non-HLA gene associated with POMS for which expression on antigen-presenting cells (APCs) is changed in response to ozone exposure.

          Objectives:

          To examine the association between county-level ozone and POMS, and the interactions between ozone pollution, CD86, and HLA- DRB1*15, the strongest genetic variant associated with POMS.

          Methods:

          Cases and controls were enrolled in the Environmental and Genetic Risk Factors for Pediatric MS study of the US Network of Pediatric MS Centers. County-level-modeled ozone data were acquired from the CDC’s Environmental Tracking Network. Participants were assigned ozone values based on county of residence. Values were categorized into tertiles based on healthy controls. The association between ozone tertiles and having MS was assessed by logistic regression. Interactions between tertiles of ozone level and the GG genotype of the rs928264 (G/A) single nucleotide polymorphism (SNP) within CD86, and the presence of DRB1*15:01 ( DRB1*15) on odds of POMS were evaluated. Models were adjusted for age, sex, genetic ancestry, and mother’s education. Additive interaction was estimated using relative excess risk due to interaction (RERI) and attributable proportions (APs) of disease were calculated.

          Results:

          A total of 334 POMS cases and 565 controls contributed to the analyses. County-level ozone was associated with increased odds of POMS (odds ratio 2.47, 95% confidence interval (CI): 1.69–3.59 and 1.95, 95% CI: 1.32–2.88 for the upper two tertiles, respectively, compared with the lowest tertile). There was a significant additive interaction between high ozone tertiles and presence of DRB1*15, with a RERI of 2.21 (95% CI: 0.83–3.59) and an AP of 0.56 (95% CI: 0.33–0.79). Additive interaction between high ozone tertiles and the CD86 GG genotype was present, with a RERI of 1.60 (95% CI: 0.14–3.06) and an AP of 0.37 (95% CI: 0.001–0.75) compared to the lowest ozone tertile. AP results indicated that approximately half of the POMS risk in subjects can be attributed to the possible interaction between higher county-level ozone carrying either DRB1*15 or the CD86 GG genotype.

          Conclusions:

          In addition to the association between high county-level ozone and POMS, we report evidence for additive interactions between higher county-level ozone and DRB1*15 and the CD86 GG genotype. Identifying gene–environment interactions may provide mechanistic insight of biological processes at play in MS susceptibility. Our work suggests a possible role of APCs for county-level ozone-induced POMS risk.

          Related collections

          Author and article information

          Contributors
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          Journal
          Multiple Sclerosis Journal
          Mult Scler
          SAGE Publications
          1352-4585
          1477-0970
          August 2022
          January 08 2022
          August 2022
          : 28
          : 9
          : 1330-1339
          Affiliations
          [1 ]University of California, San Francisco, San Francisco, CA, USA
          [2 ]Division of Child Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
          [3 ]Genetic Epidemiology and Genomics Laboratory, Divisions of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
          [4 ]The University of Utah, Salt Lake City, UT, USA
          [5 ]Buffalo General Hospital, State University of New York at Buffalo, Buffalo, NY, USA
          [6 ]Loma Linda University Children’s Hospital, Loma Linda, CA, USA
          [7 ]The University of Alabama, Tuscaloosa, AL, USA
          [8 ]University of California, San Diego, San Diego, CA, USA
          [9 ]Pediatric Multiple Sclerosis and Related Disorders Program, Boston Children’s Hospital, Boston, MA, USA
          [10 ]Cleveland Clinic, Cleveland, OH, USA
          [11 ]Washington University in St. Louis, St. Louis, MO, USA
          [12 ]Texas Children’s Hospital, Houston, TX, USA
          [13 ]University of Texas Southwestern Medical Center, Dallas, TX, USA
          [14 ]Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
          Article
          10.1177/13524585211069926
          9256753
          35000467
          4386090c-3a4a-4394-a344-583dc53cef06
          © 2022

          http://journals.sagepub.com/page/policies/text-and-data-mining-license

          History

          Comments

          Comment on this article